Cabinet approves Ship Repair Facility at Vadinar (See 'Corp Brief') Cabinet approves 3 multitracking projects covering 19 Districts (See 'Corp Brief') A&C - Argument having not been raised before Sole Arbitrator, High Court at Sec 11 stage, Commercial Court u/s 34, or in pleadings of present appeal, cannot be permitted to be advanced orally at final stage: HC (See 'Legal Desk') India-Japan cooperation in healthcare is guided by a shared vision: Nadda (See 'Corp Brief') Start-ups & MSMEs driving force to realise Viksit Bharat goal: MoS (See 'Corp Brief') A&C - If arbitration clause does not expressly specify seat of arbitration, does not identify definite venue, and does not contain exclusive jurisdiction clause, petition u/s 11(6) may be maintained: HC (See 'Legal Desk') BRO's Project Deepak celebrates 66th Raising Day (See 'Corp Brief') IPR - Appellant is a portal that reproduces university rankings & information available in public domain without alteration, editorial bias, or disparaging commentary - no interim injunction: HC (See 'Legal Desk') Capital Market - If allegation of insider trading under SEBI (PIT) Regulations, 2015 failed entirely, there is no contravention of SEBI Act: SAT (See 'Legal Desk') India witnesses Historic Expansion in Social Security: Mandaviya (See 'Corp Brief') Health Ministry releases RBSK 2.0 Guidelines at National Summit on Best Practices (See 'Corp Brief') NHAI successfully launches India's first Multi-Lane Free Flow Tolling System (See 'Corp Brief') IBC - Since MPID Act falls within State legislative field and attachment mechanism under MPID Act, especially where property already stands attached and vested in State, cannot be overridden by invoking Sec 238 or Sec 96 of IBC: HC (See 'Legal Desk') Goyal congratulates IIFT on 63rd Foundation Day (See 'Corp Brief') Outreach workshop on Atmanirbhar Panchayat Programme held at NIRD&PR, Hyderabad (See 'Corp Brief') Hyderabad should emerge as Global Hub for Yoga and Wellness: Reddy (See 'Corp Brief') IBC - If CIRP period expires without approved resolution plan, separate CoC resolution approving liquidation by 66% voting share is not required for Adjudicating Authority to order liquidation u/s 33(1)(a): NCLAT (See 'Legal Desk') Reining in Misuse of IBC for Recovery (See CORP EINSICHT)

Print

India's First Ferret Research Facility dedicated to Nation

Published: Feb 04, 2025

By TIOLCorplaws News Service

NEW DELHI, FEB 04, 2025: INDIA'S commitment to cutting-edge biomedical research and innovation took a significant leap forward with the dedication of the nation's first Ferret Research Facility, the launch of the GARBH-INi-DRISHTI data repository, and the execution of a key technology transfer agreement. The events, held at the Translational Health Science and Technology Institute (THSTI) in the NCR Biotech Science Cluster, Faridabad, Haryana, were presided over by Dr. Rajesh Gokhale, Director General, Biotechnology Research and Innovation Council and Secretary, Department of Biotechnology on 3rd Feb 2025.

The newly inaugurated THSTI Ferret Research Facility, a state-of-the-art establishment adhering to the highest biosafety and research standards, marks a pivotal moment in India's fight against infectious and non-communicable diseases. This pioneering facility will serve as a crucial resource for vaccine development, therapeutic testing, and research into emerging infectious diseases, significantly bolstering India's pandemic preparedness strategy and positioning the nation at the forefront of global scientific endeavors.

Dr. Gokhale also launched GARBH-INi-DRISHTI, the DBT Data Repository and Information Sharing Hub at THSTI. This groundbreaking platform, developed under the GARBH-INi program, provides access to an unprecedented wealth of clinical data, images, and biospecimens collected from over 12,000 pregnant women, newborns, and postpartum mothers. As one of South Asia's largest maternal and child health databases, GARBH-INi-DRISHTI will empower researchers worldwide to conduct transformative research aimed at improving maternal and neonatal health outcomes. Its foundation lies in collaborative efforts across India's leading research institutions and hospitals, representing a powerful synergy of expertise.

Furthering the drive to translate research into tangible benefits, THSTI executed a Technology Transfer Agreement with M/s Sundyota Numandis Probioceuticals Pvt. Ltd. This agreement facilitates the commercialization of THSTI's innovative, genetically defined synthetic microbial consortium, Lactobacillus crispatus . Isolated from the reproductive tracts of women enrolled in the GARBH-INi cohort, this consortium holds immense promise for nutraceutical applications, promoting overall health and well-being through targeted microbiome-based interventions.

Prof. GanesanKarthikeyan, Executive Director of THSTI, highlighted the institute's strategic role in shaping India's biotech ecosystem, emphasizing its contributions to fostering a robust environment for research and commercialization.

Dr. Gokhale lauded THSTI's commitment to translational research, recognizing the Ferret Facility as a landmark achievement placing India among select nations with such capabilities. He commended the development of GARBH-INi-DRISHTI, emphasizing its potential to empower researchers nationwide in improving birth outcomes. Dr. Gokhale also underscored the importance of technology transfer agreements in driving the biomanufacturing ecosystem and applauded THSTI's efforts in forging industry partnerships for commercialization. These combined initiatives represent a powerful confluence of scientific advancement, data-driven research, and industry collaboration, propelling India towards a healthier and more prosperous future.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.